semaglutide denmark The Ozempic effect: From shopping baskets to dips in Danish GDP A Danish pharmaceuticals maker has

At last there is a promising treatment for this chronic disease FDA-approved GLP-1 Anti-Obesity Medication (AOM) such as Wegovy and Saxenda but the cost implications are concerning

Although promising, the absence of blinding and placebo control limits the strength of causal inference (Shaaban et al., 2018)

Monitor Your Symptoms As you start treatment, keep a close eye on your symptoms

The effects of synbiotic supplementation on some cardio-metabolic risk factors in overweight and obese children: a randomized triple-masked controlled trial

Riboflavin supplementation in patients with Crohns disease [the RISE-UP study]